Activation, coactivation, and costimulation of resting human natural killer cells

被引:489
作者
Bryceson, Yenan T.
March, Michael E.
Ljunggren, Hans-Gustaf
Long, Eric O.
机构
[1] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA
[2] Karolinska Univ Hosp, Huddinge Hosp, Ctr Infect Med, Dept Med, Stockholm, Sweden
关键词
innate immunity; natural killer cell; signaling; synergy;
D O I
10.1111/j.1600-065X.2006.00457.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Natural killer (NK) cells possess potent perforin- and interferon-gamma-dependent effector functions that are tightly regulated. Inhibitory receptors for major histocompatibility complex class I display variegated expression among NK cells, which confers specificity to individual NK cells. Specificity is also provided by engagement of an array of NK cell activation receptors. Target cells may express ligands for a multitude of activation receptors, many of which signal through different pathways. How inhibitory receptors intersect different signaling cascades is not fully understood. This review focuses on advances in understanding how activation receptors cooperate to induce cytotoxicity in resting NK cells. The role of activating receptors in determining specificity and providing redundancy of target cell recognition is discussed. Using Drosophila insect cells as targets, we have examined the contribution of individual receptors. Interestingly, the strength of activation is not determined simply by additive effects of parallel activation pathways. Combinations of signals from different receptors can have different outcomes: synergy, no enhancement over individual signals, or additive effects. Cytotoxicity requires combined signals for granule polarization and degranulation. The integrin leukocyte function-associated antigen-1 contributes a signal for polarization but not for degranulation. Conversely, CD16 alone or in synergistic combinations, such as NKG2D and 2B4, signals for phospholipase-C-gamma- and phosphatidylinositol-3-kinase-dependent degranulation.
引用
收藏
页码:73 / 91
页数:19
相关论文
共 204 条
[1]
Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues [J].
Abi-Rached, L ;
Parham, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08) :1319-1332
[2]
Cutting edge: Lectin-like transcript 1 is a ligand for the CD161 receptor [J].
Aldemir, H ;
Prod'homme, V ;
Dumaurier, MJ ;
Retiere, C ;
Poupon, G ;
Cazareth, J ;
Bih, F ;
Braud, VM .
JOURNAL OF IMMUNOLOGY, 2005, 175 (12) :7791-7795
[3]
CD107a as a functional marker for the identification of natural killer cell activity [J].
Alter, G ;
Malenfant, JM ;
Altfeld, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 294 (1-2) :15-22
[4]
THE SEVERE AND MODERATE PHENOTYPES OF HERITABLE MAC-1, LFA-1 DEFICIENCY - THEIR QUANTITATIVE DEFINITION AND RELATION TO LEUKOCYTE DYSFUNCTION AND CLINICAL-FEATURES [J].
ANDERSON, DC ;
SCHMALSTEIG, FC ;
FINEGOLD, MJ ;
HUGHES, BJ ;
ROTHLEIN, R ;
MILLER, LJ ;
KOHL, S ;
TOSI, MF ;
JACOBS, RL ;
WALDROP, TC ;
GOLDMAN, AS ;
SHEARER, WT ;
SPRINGER, TA .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (04) :668-689
[5]
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors [J].
André, P ;
Castriconi, R ;
Espéli, M ;
Anfossi, N ;
Juarez, T ;
Hue, S ;
Conway, H ;
Romagné, F ;
Dondero, A ;
Nanni, M ;
Caillat-Zucman, S ;
Raulet, DH ;
Bottino, C ;
Vivier, E ;
Moretta, A ;
Paul, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (04) :961-971
[6]
Distinct role of lymphocyte fuinction-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes [J].
Anikeeva, N ;
Somersalo, K ;
Sims, TN ;
Thomas, VK ;
Dustin, ML ;
Sykulev, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (18) :6437-6442
[7]
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors [J].
Arase, H ;
Mocarski, ES ;
Campbell, AE ;
Hill, AB ;
Lanier, LL .
SCIENCE, 2002, 296 (5571) :1323-1326
[8]
Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus [J].
Arnon, TI ;
Achdout, H ;
Levi, O ;
Markel, G ;
Saleh, N ;
Katz, G ;
Gazit, R ;
Gonen-Gross, T ;
Hanna, J ;
Nahari, E ;
Porgador, A ;
Honigman, A ;
Plachter, B ;
Mevorach, D ;
Wolf, DG ;
Mandelboim, O .
NATURE IMMUNOLOGY, 2005, 6 (05) :515-523
[9]
The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46 [J].
Arnon, TI ;
Achdout, H ;
Lieberman, N ;
Gazit, R ;
Gonen-Gross, T ;
Katz, G ;
Bar-Ilan, A ;
Bloushtain, N ;
Lev, M ;
Joseph, A ;
Kedar, E ;
Porgador, A ;
Mandelboim, O .
BLOOD, 2004, 103 (02) :664-672
[10]
Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism? [J].
Arnould, L ;
Gelly, M ;
Penault-Llorca, F ;
Benoit, L ;
Bonnetain, F ;
Migeon, C ;
Cabaret, V ;
Fermeaux, V ;
Bertheau, P ;
Garnier, J ;
Jeannin, JF ;
Coudert, B .
BRITISH JOURNAL OF CANCER, 2006, 94 (02) :259-267